caffeine has been researched along with chlorocresol in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.13) | 18.7374 |
1990's | 11 (23.40) | 18.2507 |
2000's | 31 (65.96) | 29.6817 |
2010's | 3 (6.38) | 24.3611 |
2020's | 1 (2.13) | 2.80 |
Authors | Studies |
---|---|
Scutari, E; Tegazzin, V; Treves, S; Zorzato, F | 1 |
Herrmann-Frank, A; Lehmann-Horn, F; Richter, M | 1 |
Li, G; Pralong, WF; Wollheim, CB | 1 |
Bittner, RE; Fricker, R; Gilly, H; Kress, HG; Musat, I; Steinbereithner, K | 1 |
Adnet, PJ; Ben-Abraham, R; Haudcoeur, G; Krivosic-Horber, RM; Perel, A | 1 |
Bendixen, D; Fagerlund, T; Gardi, T; Glahn, K; Ording, H | 1 |
Andrade, FH; Islam, MS; Westerblad, H | 1 |
Du, GG; MacLennan, DH | 1 |
Allen, DG; Kabbara, AA | 1 |
Choisy, S; Huchet-Cadiou, C; Leoty, C | 2 |
Bao, JX; Copenhagen, DR; Krizaj, D; Schmitz, Y; Witkovsky, P | 1 |
Baur, CP; Bellon, L; Felleiter, P; Fiege, M; Fricker, R; Georgieff, M; Glahn, K; Heffron, JJ; Herrmann-Frank, A; Jurkat-Rott, K; Klingler, W; Lehane, M; Lehmann-Horn, F; Ording, H; Tegazzin, V; Wappler, F | 1 |
Allen, PD; Chen, SR; Fessenden, JD; Moore, RA; Pessah, IN; Wang, Y | 1 |
Choisy, S; Divet, A; Huchet-Cadiou, C; Léoty, C | 1 |
Moccagatta, L; Pouliquin, R; Treves, S; Zorzato, F | 1 |
Cohen, J; Hentschel, J; Klauke, N; Mohamed, I; Plattner, H | 1 |
Koenig, F; Neuhaus, J; Olthoff, D; Rueffert, H; Wehner, M | 1 |
Fuller, GA; Ishida, K; Klomkleaw, W; Kurono, C; Nakajima, R; Oba, T; Takaishi, T; Yamaguchi, M | 1 |
Allen, PD; López, JR | 1 |
Bina, S; Brandom, BW; Daly, JW; Gallagher, KL; Holman, SJ; Hosoi, E; Muldoon, S; Pudimat, PA; Sei, Y; Venzon, DJ; Wyre, HW | 1 |
Freymond, D; Guignet, R; Lhote, P; Passaquin, AC; Rüegg, UT | 1 |
Allen, PD; Pessah, IN; Ta, TA; Yang, T | 1 |
Allen, PD; Fessenden, JD; Goth, S; Perez, CF; Pessah, IN | 1 |
Graves, TK; Hinkle, PM | 1 |
Anetseder, M; Baur, CP; Censier, K; Doetsch, S; Felleiter, P; Fiege, M; Fricker, R; Halsall, PJ; Hartung, E; Heffron, JJ; Heytens, L; Hopkins, PM; Klingler, W; Lehmann-Horn, F; Nivoche, Y; Schulte am Esch, J; Tegazzin, V; Tzanova, I; Urwyler, A; Wappler, F; Weisshorn, R | 1 |
George, CH; Higgs, GV; Lai, FA | 1 |
BIGGS, DF | 1 |
Koenig, F; Olthoff, D; Rueffert, H; Wehner, M | 2 |
Kress, HG; Ludwig-Papst, C; Weigl, LG | 1 |
Allen, PD; Feng, W; Fessenden, JD; Pessah, IN | 1 |
Allen, PD; Linares, N; López, JR; Pessah, IN | 1 |
Ducreux, S; Ferreiro, A; Jungbluth, H; Monnier, N; Müller, CR; Muntoni, F; Treves, S; Zorzato, F | 1 |
Bina, S; Bünger, R; Cowan, G; Karaian, J; Mongan, P; Muldoon, S | 1 |
Higure, Y; Nohmi, M; Shimazaki, Y | 1 |
Butler, T; Klein, MG; McKinney, LC; Mullen, SP | 1 |
Allard, B; Couchoux, H; Jacquemond, V; Pouvreau, S | 1 |
Fogarty, KE; Lifshitz, LM; Singer, JJ; Tuft, RA; Zhang, YA; Zou, H | 1 |
Liu, QH; Rathore, R; Wang, QS; Wang, YX; Yadav, V; Zheng, YM | 1 |
Kaufmann, A; Kraft, B; Michalek-Sauberer, A; Weigl, LG | 1 |
Meur, G; Rosker, C; Taylor, CW; Taylor, EJ | 1 |
Girard, T; Levano, S; Matter, A; Singer, M; Treves, S; Urwyler, A; Vukcevic, M | 1 |
Hamada, H; Kawamoto, M; Kobayashi, M; Migita, T; Mukaida, K; Yuge, O | 1 |
Johannsen, S; Mögele, S; Müller, CR; Roewer, N; Schneiderbanger, D; Schuster, F; Treves, S | 1 |
Hamada, H; Kanzaki, R; Kawamoto, M; Kondo, T; Miyoshi, H; Mukaida, K; Nishino, I; Otsuki, S; Yasuda, T | 1 |
Almássy, J; Bárdi, M; Diszházi, G; Jóna, I; Kovács, T; Lukács, B; Magyar, ZÉ; Márton, I; Nánási, P; Novák, S; Péli-Szabó, J; Sárközi, S; Skaliczki, M | 1 |
2 trial(s) available for caffeine and chlorocresol
Article | Year |
---|---|
A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility.
Topics: Caffeine; Central Nervous System Stimulants; Cresols; Europe; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Regression Analysis; Risk Assessment | 2000 |
Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Sensitivity and Specificity | 2003 |
45 other study(ies) available for caffeine and chlorocresol
Article | Year |
---|---|
Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Cresols; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscle Proteins; Neuromuscular Depolarizing Agents; Rabbits; Ryanodine Receptor Calcium Release Channel; Succinylcholine | 1996 |
4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle.
Topics: Animals; Caffeine; Calcium; Cresols; Malignant Hyperthermia; Muscle, Skeletal; Protein Binding; Ryanodine; Swine; Tritium | 1996 |
Oscillations of cytosolic free calcium in bombesin-stimulated HIT-T15 cells.
Topics: Animals; Biological Clocks; Bombesin; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Cell Line; Central Nervous System Stimulants; Chelating Agents; Circadian Rhythm; Cresols; Cricetinae; Cytosol; Diazoxide; Egtazic Acid; Fura-2; Glucose; Hydroquinones; Membrane Potentials; Ryanodine; Verapamil | 1996 |
Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Halothane; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle, Skeletal; Sensitivity and Specificity | 1997 |
[Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Topics: Adolescent; Adult; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Phenotype | 1997 |
4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Ryanodine | 1997 |
Effects of ryanodine receptor agonist 4-chloro-m-cresol on myoplasmic free Ca2+ concentration and force of contraction in mouse skeletal muscle.
Topics: Animals; Caffeine; Calcium; Chlorophenols; Cresols; Dantrolene; Electric Stimulation; Male; Membrane Potentials; Mice; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 1998 |
Functional consequences of mutations of conserved, polar amino acids in transmembrane sequences of the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Caffeine; Calcium; Cell Line; Conserved Sequence; Cresols; Humans; Kinetics; Macromolecular Substances; Molecular Sequence Data; Muscle, Skeletal; Mutagenesis, Site-Directed; Point Mutation; Rabbits; Recombinant Proteins; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sequence Alignment; Sequence Homology, Amino Acid; Transfection; Valine | 1998 |
Measurement of sarcoplasmic reticulum Ca2+ content in intact amphibian skeletal muscle fibres with 4-chloro-m-cresol.
Topics: Animals; Bufo marinus; Caffeine; Calcium; Central Nervous System Stimulants; Cresols; Dose-Response Relationship, Drug; Electrophysiology; Indoles; Muscle, Skeletal; Sarcoplasmic Reticulum | 1999 |
Sarcoplasmic reticulum Ca(2+) release by 4-chloro-m-cresol (4-CmC) in intact and chemically skinned ferret cardiac ventricular fibers.
Topics: Animals; Caffeine; Calcium; Contractile Proteins; Cresols; Ferrets; Heart Ventricles; In Vitro Techniques; Kinetics; Male; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Octoxynol; Ryanodine Receptor Calcium Release Channel; Saponins; Sarcoplasmic Reticulum | 1999 |
Caffeine-sensitive calcium stores regulate synaptic transmission from retinal rod photoreceptors.
Topics: Ambystoma; Animals; Barium; Caffeine; Calcium; Calcium Channels; Chelating Agents; Cresols; Egtazic Acid; Electrophysiology; In Vitro Techniques; Kinetics; Models, Neurological; Presynaptic Terminals; Retinal Rod Photoreceptor Cells; Ryanodine; Synaptic Transmission; Thymol; Xenopus laevis | 1999 |
Differential effects of 4-chloro-m-cresol and caffeine on skinned fibers from rat fast and slow skeletal muscles.
Topics: Animals; Caffeine; Calcium; Contractile Proteins; Cresols; In Vitro Techniques; Male; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Octoxynol; Rats; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Surface-Active Agents | 2000 |
Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line.
Topics: Animals; Biophysical Phenomena; Biophysics; Caffeine; Calcium Signaling; Cell Line; Cresols; Electrophysiology; Gene Expression; Herpesvirus 1, Human; Mice; Muscle Contraction; Muscle, Skeletal; Protein Isoforms; Recombinant Proteins; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tacrolimus Binding Protein 1A; Transduction, Genetic | 2000 |
Sarcoplasmic reticulum Ca(2+) content affects 4-CmC and caffeine contractures of rat skinned skeletal muscle fibers.
Topics: Animals; Caffeine; Calcium; Cresols; Dose-Response Relationship, Drug; Fungicides, Industrial; Male; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Weight-Bearing | 2001 |
Functional properties of EGFP-tagged skeletal muscle calcium-release channel (ryanodine receptor) expressed in COS-7 cells: sensitivity to caffeine and 4-chloro-m-cresol.
Topics: Animals; Caffeine; Calcium; Central Nervous System Stimulants; COS Cells; Cresols; Fluorescent Antibody Technique; Green Fluorescent Proteins; Luminescent Proteins; Recombinant Proteins; Ryanodine Receptor Calcium Release Channel; Tritium | 2002 |
Functional and fluorochrome analysis of an exocytotic mutant yields evidence of store-operated Ca2+ influx in Paramecium.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Cell Line; Cresols; Dextrans; Exocytosis; Fluorescent Dyes; Mutation; Paramecium tetraurelia; Sensitivity and Specificity | 2002 |
Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation.
Topics: Amino Acid Substitution; Caffeine; Calcium; Cresols; Female; Humans; Male; Malignant Hyperthermia; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Pedigree; Potassium Chloride; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 2002 |
H2O2 activates ryanodine receptor but has little effect on recovery of releasable Ca2+ content after fatigue.
Topics: Animals; Caffeine; Calcium; Catalase; Cresols; Homeostasis; Hydrogen Peroxide; Membrane Potentials; Muscle Contraction; Muscle Fatigue; Oxidants; Oxidation-Reduction; Phosphodiesterase Inhibitors; Rana catesbeiana; Recovery of Function; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 2002 |
"Noninvasive" testing for malignant hyperthermia susceptibility.
Topics: Caffeine; Calcium; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction | 2002 |
Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
Topics: Adolescent; Adult; B-Lymphocytes; Caffeine; Calcium; Child; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Mutation; Ryanodine Receptor Calcium Release Channel | 2002 |
Calcium homeostasis and glucose uptake of murine myotubes exposed to insulin, caffeine and 4-chloro-m-cresol.
Topics: Animals; Caffeine; Calcium; Cell Line; Cresols; Cytosol; Dose-Response Relationship, Drug; Glucose; Homeostasis; Insulin; L-Lactate Dehydrogenase; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Ryanodine Receptor Calcium Release Channel | 2002 |
Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Topics: Animals; Caffeine; Calcium; Cell Membrane; Central Nervous System Stimulants; Collagen; Cresols; DNA, Complementary; Dose-Response Relationship, Drug; Drug Combinations; Herpesvirus 1, Human; Immunoblotting; Inhibitory Concentration 50; Laminin; Magnesium; Malignant Hyperthermia; Mice; Muscle Contraction; Muscle, Skeletal; Muscles; Mutation; Potassium Chloride; Protein Structure, Tertiary; Proteoglycans; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel | 2003 |
Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol.
Topics: Animals; Caffeine; Calcium; Cresols; Gene Expression; Molecular Weight; Muscle Fibers, Skeletal; Mutagenesis, Site-Directed; Potassium Chloride; Protein Isoforms; Rabbits; Recombinant Fusion Proteins; Ryanodine; Ryanodine Receptor Calcium Release Channel; Structure-Activity Relationship; Transfection; Tritium | 2003 |
Ca(2+)-induced Ca(2+) release in the pancreatic beta-cell: direct evidence of endoplasmic reticulum Ca(2+) release.
Topics: Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Carbachol; Cell Line; Cresols; Cytoplasm; Endoplasmic Reticulum; Glucose; Islets of Langerhans; Membrane Potentials; Potassium Chloride; Ryanodine; Ryanodine Receptor Calcium Release Channel; Type C Phospholipases | 2003 |
Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Caffeine; Calcium; Cell Line; Cresols; Humans; Isoproterenol; Mutation; Myocytes, Cardiac; Phenotype; Ryanodine Receptor Calcium Release Channel; Stress, Physiological; Tachycardia, Ventricular; Tacrolimus Binding Proteins | 2003 |
EXPERIMENTS ON THE MECHANISM OF ACTION OF CHLOROCRESOL AND CAFFEINE.
Topics: Acetylcholine; Animals; Anura; Caffeine; Calcium; Cholinesterase Inhibitors; Cresols; Cyanides; Edetic Acid; Fluorides; Fructose; Gallamine Triethiodide; Glucose; Hexosephosphates; Iodoacetates; Metabolism; Muscle Contraction; Pharmacology; Potassium Chloride; Procaine; Research; Sodium; Tubocurarine | 1965 |
Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.
Topics: Adult; Aged; Caffeine; Calcium; Child; Child, Preschool; Cresols; Female; Genetic Predisposition to Disease; Halothane; Heterozygote; Humans; Male; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle Fibers, Skeletal; Point Mutation; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 2003 |
Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
Topics: Adolescent; Adult; Aged; Anesthetics; Biopsy; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Child; Child, Preschool; Cresols; Dose-Response Relationship, Drug; Exons; Family Health; Fungicides, Industrial; Fura-2; Halothane; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Middle Aged; Molecular Biology; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Ryanodine Receptor Calcium Release Channel | 2004 |
4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.
Topics: Caffeine; Calcium; Calibration; Cells, Cultured; Central Nervous System Stimulants; Cresols; DNA Mutational Analysis; DNA, Complementary; Fluorescent Dyes; Fura-2; Humans; Malignant Hyperthermia; Microtubules; Muscle Contraction; Muscle, Smooth, Vascular; RNA, Messenger; Ryanodine Receptor Calcium Release Channel | 2004 |
Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1.
Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Caffeine; Calcium; Cresols; DNA Mutational Analysis; DNA, Complementary; Dose-Response Relationship, Drug; Fungicides, Industrial; Immunoblotting; Mice; Molecular Sequence Data; Muscle, Skeletal; Muscles; Mutation; Phosphodiesterase Inhibitors; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sequence Homology, Amino Acid | 2004 |
Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i.
Topics: Animals; Animals, Newborn; Caffeine; Calcium; Central Nervous System Stimulants; Chelating Agents; Cresols; Egtazic Acid; Electrophysiology; Fungicides, Industrial; Malignant Hyperthermia; Membrane Potentials; Microelectrodes; Muscle, Skeletal; Swine | 2005 |
Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes.
Topics: Amino Acid Substitution; Caffeine; Calcium Signaling; Case-Control Studies; Cells, Cultured; Cresols; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Herpesvirus 4, Human; Humans; Lymphocytes; Mutation; Myopathy, Central Core; Ryanodine Receptor Calcium Release Channel; Thapsigargin | 2006 |
Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Topics: Anesthesia, General; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Blood Gas Analysis; Caffeine; Central Nervous System Stimulants; Creatine Kinase; Cresols; Dose-Response Relationship, Drug; Electrolytes; Glucose; Halothane; Ketamine; Lactic Acid; Malignant Hyperthermia; Microdialysis; Muscle, Skeletal; Propofol; Pyruvic Acid; Ryanodine Receptor Calcium Release Channel; Swine | 2006 |
Can 4-chloro-m-cresol be substituted for caffeine as an activator of calcium oscillation in bullfrog sympathetic ganglion cells?
Topics: Animals; Caffeine; Calcium Signaling; Cells, Cultured; Cresols; Dose-Response Relationship, Drug; Ganglia, Sympathetic; Rana catesbeiana; Ryanodine | 2006 |
Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia.
Topics: Animals; B-Lymphocytes; Caffeine; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cells, Cultured; Cresols; Dose-Response Relationship, Drug; Humans; Imidazoles; Malignant Hyperthermia; Oxazoles; Ryanodine; Ryanodine Receptor Calcium Release Channel; Swine | 2006 |
Sarcoplasmic reticulum Ca2+ release and depletion fail to affect sarcolemmal ion channel activity in mouse skeletal muscle.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cresols; Delayed Rectifier Potassium Channels; Enzyme Inhibitors; In Vitro Techniques; Indoles; Ion Channel Gating; Male; Membrane Potentials; Mice; Mice, Inbred mdx; Muscle, Skeletal; Patch-Clamp Techniques; Sarcolemma; Sarcoplasmic Reticulum | 2006 |
Caffeine-activated large-conductance plasma membrane cation channels in cardiac myocytes: characteristics and significance.
Topics: Animals; Arrhythmias, Cardiac; Caffeine; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cell Membrane; Cresols; Enzyme Inhibitors; Heart Atria; Heart Ventricles; In Vitro Techniques; Ion Channel Gating; Membrane Potentials; Mice; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Ruthenium Red; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tetracaine; Thapsigargin | 2007 |
Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.
Topics: Animals; Caffeine; Calcium Signaling; Cell Hypoxia; Cresols; Gene Expression Regulation; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium; Pulmonary Artery; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ryanodine Receptor Calcium Release Channel | 2008 |
Novel ryanodine receptor mutation that may cause malignant hyperthermia.
Topics: Amino Acid Substitution; Anesthetics, Inhalation; Austria; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Child; Cresols; Dose-Response Relationship, Drug; Female; Halothane; Humans; Male; Malignant Hyperthermia; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Patch-Clamp Techniques; Polymerase Chain Reaction; RNA, Messenger; Ryanodine Receptor Calcium Release Channel | 2008 |
Functional ryanodine receptors in the plasma membrane of RINm5F pancreatic beta-cells.
Topics: Animals; Caffeine; Calcium; Calcium Channel Agonists; Cell Line, Tumor; Cell Membrane; Central Nervous System Stimulants; Cresols; Dose-Response Relationship, Drug; Fungicides, Industrial; Inositol 1,4,5-Trisphosphate Receptors; Insulin-Secreting Cells; Male; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel | 2009 |
Increasing the number of diagnostic mutations in malignant hyperthermia.
Topics: Caffeine; Calcium; Cell Line, Transformed; Cresols; DNA Mutational Analysis; Dose-Response Relationship, Drug; Family Health; Gene Frequency; Genetic Testing; Genotype; Humans; Lymphocytes; Malignant Hyperthermia; Mutation; Phenotype; Ryanodine Receptor Calcium Release Channel | 2009 |
Analysis of human cultured myotubes responses mediated by ryanodine receptor 1.
Topics: Adolescent; Adult; Aged; Caffeine; Calcium; Cells, Cultured; Child; Child, Preschool; Cresols; Dose-Response Relationship, Drug; Female; Genetic Predisposition to Disease; Halothane; Humans; Male; Malignant Hyperthermia; Middle Aged; Muscle Fibers, Skeletal; ROC Curve; Ryanodine Receptor Calcium Release Channel; Young Adult | 2011 |
Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia.
Topics: Anesthetics; Arginine; B-Lymphocytes; Caffeine; Cell Line, Transformed; Cresols; Family Health; Female; Fungicides, Industrial; Genetic Predisposition to Disease; Germany; Halothane; Humans; Male; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Phosphodiesterase Inhibitors; Polymorphism, Single Nucleotide; Ryanodine Receptor Calcium Release Channel; Tryptophan | 2016 |
Genetic and functional analysis of the RYR1 mutation p.Thr84Met revealed a susceptibility to malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Child; Cresols; Genetic Predisposition to Disease; HEK293 Cells; Humans; Male; Malignant Hyperthermia; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Rabbits; Ryanodine Receptor Calcium Release Channel | 2018 |
4-chloro-orto-cresol activates ryanodine receptor more selectively and potently than 4-chloro-meta-cresol.
Topics: Adenosine Triphosphatases; Animals; Caffeine; Calcium; Cresols; Hydrolysis; Ion Channel Gating; Ions; Microsomes; Muscle Contraction; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Stereoisomerism | 2020 |